Complete routine immunisation schedule from 1 July 2026
Updated 17 August 2026
Complete routine immunisation schedule
| Eight weeks old | Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B |
DTaP/IPV/Hib/HepB (6 in 1 vaccine) |
Infanrix hexa or Vaxelis |
Thigh |
| Meningococcal group B (MenB) | MenB | Bexsero | Thigh | |
| Rotavirus gastroenteritis | Rotavirus | Rotarix[footnote 2] | By mouth | |
| Twelve weeks old | Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B |
DTaP/IPV/Hib/HepB (6 in 1 vaccine) |
Infanrix hexa or Vaxelis |
Thigh |
| MenB | MenB | Bexsero | Thigh | |
| Rotavirus | Rotavirus | Rotarix[footnote 2] | By mouth | |
| Sixteen weeks old | Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B |
DTaP/IPV/Hib/HepB (6 in 1 vaccine) |
Infanrix hexa or Vaxelis |
Thigh |
| Pneumococcal (13 serotypes) | PCV | Prevenar 13 | Thigh | |
| One year old (on or after the child’s first birthday | Pneumococcal MenB Measles, mumps, rubella, varicella |
PCV MenB MMRV |
Prevenar 13 Bexsero ProQuad or Priorix Tetra |
Upper arm or thigh |
| Eighteen months old |
Born on or after 1 July 2024 Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B Measles, mumps, rubella, varicella Born on or before 30 June 2024 No appointment |
DTaP/IPV/Hib/HepB MMRV |
Infanrix hexa or Vaxelis ProQuad or Priorix Tetra |
Upper arm or thigh |
| Three years four months old or soon after |
Born on or after 1 January 2025 Diphtheria, tetanus, pertussis and polio Born on or before 31 December 2024 Diphtheria, tetanus, pertussis and polio Measles, mumps, rubella, varicella |
dTaP/IPV MMRV |
REPEVAX ProQuad or Priorix Tetra |
Upper arm |
| Boys and girls aged twelve to thirteen years | Cancers and genital warts caused by specific human papillomavirus (HPV) types |
HPV | Gardasil 9 | Upper arm |
| Fourteen years old (school year 9) | Tetanus, diphtheria and polio | Td/IPV | REVAXIS | Upper arm |
| Meningococcal groups A, C, W and Y | MenACWY | MenQuadfi | Upper arm | |
| 65 years old | Pneumococcal (23 or 20 serotypes) | Pneumococcal polysaccharide vaccine (PPV23) or Pneumococcal conjugate vaccine (PCV20) once PPV23 stock exhausted |
Pneumovax 23 Prevenar 20 |
Upper arm |
| 65 years of age and older | Influenza (each year from September) | Inactivated influenza vaccine | Multiple | Upper arm |
| Individuals turning 65 from 1 Sept each year (commencing 1 Sept 2023 onwards) |
Shingles | Shingles vaccine | Shingrix | Upper arm |
| 70 to 79 years of age (and those severely immunosuppressed over 18 years of age) |
Shingles | Shingles vaccine | Shingrix | Upper arm |
| 75 years of age All adult residents in care homes for older adults |
Respiratory syncytial virus (RSV) | RSV vaccine | Abrysvo | Upper arm |
|
Eligible paediatric age group See annual flu letter |
Influenza (each year from September) | Live attenuated influenza vaccine (LAIV) • If LAIV is contraindicated or otherwise unsuitable use inactivated flu vaccine (check Green Book Chapter 19 for details) |
Fluenz (Contains porcine gelatine) |
Both nostrils |
Selective immunisation programmes
| Target group | Age and schedule | Disease | Vaccines required |
|---|---|---|---|
| Babies born to women with hepatitis B infection[footnote 3][footnote 4] | At birth and four weeks | Hepatitis B | Hepatitis B (Engerix B/HBvaxPRO) |
| Infants in areas of the country with TB incidence >= 40/100,000 | Within 28 days of birth[footnote 6] | Tuberculosis | BCG |
| Infants with a parent or grandparent born in a high incidence country[footnote 5] | Within 28 days of birth[footnote 6] | Tuberculosis | BCG |
| Children in a clinical risk group | Aged 6 months to under 2 years • if first ever flu vaccine give second dose at 4 weeks |
Influenza | Inactivated flu vaccine |
| Aged 2 to 8 years • if first ever flu vaccine give second dose at 4 weeks |
LAIV (Fluenz) • if LAIV contraindicated or otherwise unsuitable give inactivated flu |
||
| Aged 9 to 17 years • only one dose required each flu season |
LAIV (Fluenz) • if LAIV contraindicated or otherwise unsuitable give inactivated flu |
||
| Pregnant women | At any stage of pregnancy during flu season | Influenza | Inactivated flu vaccine |
| From 16 weeks gestation[footnote 7] | Pertussis | Tdap (ADACEL) the vaccine given also provides protection against tetanus and diphtheria | |
| From 28 weeks gestation | RSV | RSV vaccine (Abrysvo) |
Additional vaccines for individuals with underlying medical conditions
| Medical condition (see Green Book for full details) | Diseases protected | Vaccines required |
|---|---|---|
| Asplenia or splenic dysfunction (this also includes individuals with coeliac disease who are diagnosed with splenic dysfunction and all haemoglobinopathies including homozygous sickle cell disease) | Meningococcal groups A, B, C, W and Y Pneumococcal Influenza |
MenACWY MenB PCV13 (PCV20 once available) (up to 2 years of age)[footnote 8] PPV23 (PCV20 once PPV23 stocks exhausted) (from 2 years of age)[footnote 8] |
| Complement disorders (including those receiving complement inhibitor therapy) | ||
| Cochlear implants | Pneumococcal | PCV13 (up to 2 years of age)[footnote 8] PPV23 (PCV20 once PPV23 stocks exhausted) (from 2 years of age)[footnote 8] |
| Chronic respiratory and heart conditions (such as severe asthma, chronic pulmonary disease, and heart failure) | Pneumococcal Influenza |
PCV13 (up to 2 years of age)[footnote 8] PPV23 (PCV20 once PPV23 stocks exhausted) (from 2 years of age)[footnote 8] |
| Chronic neurological conditions | Pneumococcal (only if the individual is also at risk of aspiration) Influenza |
PCV13 (up to 2 years of age)[footnote 8] PPV23 (PCV20 once PPV23 stocks exhausted) (from 2 years of age)[footnote 8] Annual flu vaccine |
| Diabetes | Pneumococcal Influenza |
PCV13 (up to 2 years of age)[footnote 8] PPV23 (PCV20 once PPV23 stocks exhausted) (from 2 years of age)[footnote 8] Annual flu vaccine |
| Chronic kidney disease (CKD) (including haemodialysis) | Pneumococcal (stage 4 and 5 CKD) Influenza (stage 3, 4 and 5 CKD) Hepatitis B (stage 4 and 5 CKD) |
PCV13 (up to 2 years of age)[footnote 8] PPV23 (PCV20 once PPV23 stocks exhausted) (from 2 years of age)[footnote 8] Annual flu vaccine Hepatitis B |
| Chronic liver conditions | Pneumococcal Influenza Hepatitis A Hepatitis B |
PCV13 (up to 2 years of age)[footnote 8] PPV23 (PCV20 once PPV23 stocks exhausted) (from 2 years of age)[footnote 8] Annual flu vaccine Hepatitis A Hepatitis B |
| Haemophilia | Hepatitis A Hepatitis B |
Hepatitis A Hepatitis B |
| Immunosuppression due to disease or treatment | Pneumococcal Influenza |
PCV13 (up to 2 years of age)[footnote 8] PPV23 (PCV20 once PPV23 stocks exhausted) (from 2 years of age)[footnote 8] Annual flu vaccine[footnote 9] |
| Severe immunosuppression | Pneumococcal Shingles vaccine Influenza |
PCV13 (up to 2 years of age)[footnote 8] PPV23 (PCV20 once PPV23 stocks exhausted) (from 2 years of age)[footnote 8] Annual flu vaccine[footnote 9] Shingrix - from 18 years of age[footnote 10] |
-
Rotavirus vaccine should only be given after checking for SCID screening result. ↩ ↩2
-
Take blood for HBsAg anytime between 12 and 18 months to test for infection. ↩
-
In addition hexavalent vaccine (Infanrix hexa or Vaxelis) is given at 8, 12 and 16 weeks and also at 18 months. ↩
-
Where the annual incidence of TB is >= 40/100,000 – see tuberculosis by country. ↩
-
Ideally before 32 weeks gestation but may still be given after 32 weeks. ↩
-
Check relevant chapter of the Green Book for specific schedule. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18
-
Refer to the Green Book Pneumococcal chapter for the number and timing of doses for these individuals. ↩ ↩2
-
Also consider annual influenza vaccination for household members and those who care for these individuals. ↩